Loading stock data…
$7.06-0.03 (-0.42%)
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space.
SOPHiA GENETICS SA in the Healthcare sector is trading at $7.06 with a market capitalization of $712M. Wall Street consensus targets $9.75 (4 analysts), implying a +38.1% move over the next 12 months. The stock is currently 21% below its 52-week high of $8.98, remaining 21.5% above its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 28 is oversold, raising the odds of a near-term bounce. The Whystock Score of 80/100 reflects bullish alignment across trend, valuation and analyst targets.
| Metric (USD) | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|
| Total Revenue | $23.31M↑ | $21.69M | $21.71M↑ | $19.46M↑ | $18.32M |
| Gross Profit | $15.06M↑ | $14.75M↑ | $14.69M↑ | $12.91M↑ | $12.27M |
| Operating Income | -$20.05M↓ | -$17.28M↑ | -$18.52M↓ | -$17.86M↑ | -$18.49M |
| Net Income | -$22.36M↓ | -$19.32M↓ | -$19.18M↑ | -$20.02M↑ | -$22.41M |
SOPHiA GENETICS SA operates as a cloud-native software technology company in the healthcare space. It offers SOPHiA DDM platform, a cloud-native software platform for analyzing data and generating insights from multimodal data sets and diagnostic mod...